Continuous Glucose Monitor Use in Pregnancy
Recruiting now · Not applicable
Conditions studied: Type 2 Diabetes Treated With Insulin, Pregnancy, High Risk
In brief
The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.
Key facts
- Study ID
- NCT05317585
- Run by
- University of Massachusetts, Worcester
- People needed
- 180
- Starts
- 2024-05-23
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.